News

By MELINDA J. OVERSTREET for Glasgow News 1 In September 2023, he had been fighting a cold for weeks and weeks. His immune ...
Regeneron Pharmaceuticals gains FDA approval for Lynozyfic drug targeting multiple myeloma, with launch details and executive ...
Regeneron Pharmaceuticals has received accelerated FDA approval for Lynozyfic, a new bispecific antibody treatment for adults with relapsed or refractory multiple myeloma who have undergone at least ...
The Food and Drug Administration (FDA) has granted accelerated approval to Lynozyfic™ (linvoseltamab-gcpt) for the treatment of adult patients with ...
The U.S. Food and Drug Administration has approved Regeneron Pharmaceuticals' Lynozyfic, a therapy for recurrent multiple myeloma, boosting the company's shares by 2%.
Kansas City, Kansas, residents are suing Harcros Chemicals, accusing the company of poisoning the air for decades with a “toxic cocktail” of emissions – leading to the deaths of ...
Plans are under way to bring life-saving cell-based cancer treatments to patients in New Zealand. Dr Alicia Didsbury from the ...
Antibody-Drug Conjugates (ADC) Market- Driven by Advanced Payload Technologies and Strategic Industry Partnerships Sai Kumar DataM Intelligence 4market Research LLP +1 877-441-4866 ... Visit us on ...
Bruce Springsteen and Patti Scialfa have been married for decades, but their lives aren't perfect; things took a tragic turn ...
From July 26-27, over a thousand cyclists will converge in Mequon, Wisconsin, to participate in the 33rd Annual Scenic Shore ...